Research suggests that the available evidence for cayenne pepper as a pain relief intervention is extremely limited in the context of the linked studies, with only a single industry-funded laboratory study examining sore throat inflammation and related pain mechanisms. That study, which used human respiratory cells and three-dimensional tissue models rather than human clinical trials, investigated inflammatory mediators like bradykinin and found that certain anti-inflammatory combinations could reduce these markers, though cayenne pepper was not itself a primary focus of the findings. The study's conclusions are significantly constrained by the fact that it was entirely funded by the company selling the product being tested, and all authors were company employees, raising clear concerns about potential bias. Readers should be aware that this single preclinical study does not constitute sufficient evidence to draw broad conclusions about cayenne pepper's effectiveness for pain relief, and a much stronger body of independent clinical research would be needed to support such claims.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| A novel anti-inflammatory treatment for bradykinin-induced sore throat or pha... | Other | 2020 | — | 85 |